. The products obtained by introduction of heteroatom in the steroid nucleus are called nuclear heterosteroids. When heteroatom(s) forms a part of fused ring system, attached group or a side chain of the steroid nucleus then the products are known as extranuclear heterosteroids. Heterosteroids encompass a wide range of compounds with varied biological activities, e.g., 5a-reductase inhibitors like finasteride [2] , GABA receptor antagonists, e.g., RU-5135 [2] , aromatase inhibitors such as formestane and exemestane [3] , anticancer agents like 2-methoxyestradiol [4] and neuromuscular junction blocking agents like pipecuronium [5] . 16 -Substituted steroids have shown diversified pharmacological activities and are of interest for a medicinal chemist to develop new molecules. Many potent steroidal derivatives with substitution at position 16 have been described in the literature [6, 7] . Some interesting 16E-arylidenosteroids have recently been reported from our laboratory as strong in vitro inhibitors of the growth of many types of human tumor cells [8] [9] [10] . These findings motivated us to continue the exploration of biological properties of 16- substituted steroidal derivatives by designing and synthesizing new analogues with suitable structural modifications. This paper embodies the synthesis, study and biological 3 evaluation of newer 16-imidazolyl substituted steroids for their cytotoxic, aromatase inhibitory, NMJ blocking and acetylcholinesterase inhibitory activities.
Development of hybrid structures, in which pharmacologically crucial structural elements from two molecules are combined to produce a non-identical twin drug, is a rational approach to obtain therapeutically useful molecules. The main focus of the current study is to design and develop synthetic strategies to produce new chemical hybrids of steroidal aromatase inhibitors such as formestane, exemestane and nonsteroidal aromatase inhibitors, e.g., fadrozole (fig 1) . These compounds may show high specificity and increased potency as aromatase inhibitors. In view of the significance of azole moiety to inhibit P450 enzyme inhibitors including aromatase [11, 12] , we hypothesized that introducing imidazole moiety to the androstane nucleus might yield specific and potent P450 inhibitors. With this design, it may be possible to produce substrate like chemical entities, which not only interact with the steroid binding site of the enzyme, thus introducing high specificity, but also provide a ligand to the enzyme heme iron resulting in tight binding [13] . Literature survey further indicates that structural modifications in steroidal A and D ring brings out noticeable changes in aromatase inhibitory potential of steroidal molecules and provides potent, easily obtainable and structurally simple aromatase inhibitors [7, 14, 15] . Therefore, as performed with non-steroidal inhibitors [16] [17] [18] , imidazolyl-substituted D-ring modified steroidal derivatives containing a suitably positioned heteroatom capable of binding to cytochrome P450 enzymes have been synthesized. Neuromuscular junction blocking agents act on cholinergic receptors on the skeletal muscle endplate to produce muscle paralysis. These agents are clinically used to provide adequate skeletal neuromuscular relaxation during surgery, controlled respiration 4 and orthopedic manipulation. These agents are used to induce safer anesthesia, decrease the severity of muscle contraction during electroconvulsive treatment and may also be used in the management of tetanus, in various spastic disorders and in diagnosis of myasthenia gravis [2, 5] .
Quaternary ammonium steroids represent an important class of skeletal muscle relaxants [5] . These are non-depolarising type NMJ blockers and act as competitive antagonists at the acetylcholine receptors. The block can be reversed by acetylcholinesterase inhibitors due to increase in concentration of acetylcholine at the junction by inhibiting the enzyme acetylcholinesterase. Most of the acetylcholinesterase inhibitors are also quaternary ammonium compounds [19] . Interonium distance between the two quaternary centres in steroids is crucial for NMJ blocking activity. It has also been observed from our previous studies that a variation in the interonium distance, although increased, resulting from the built in flexibility about the single bond on the moieties linked to ring D of a bisquaternary steroid is not desirable for favourable NMJ blocking effects [19] . Pipecuronium bromide with an interonium distance of 16.07 Å produces less cardiovascular side effects in comparison to pancuronium bromide (11.00 Å) (fig 2) [20, 21] , however an increase in onset of action was observed. A value of about 10-14 Å is considered as optimal interonium distance for skeletal muscle relaxant effects. Taking a note of this observation, some biquaternary steroids with a little extended, but fixed interonium distance has also been prepared and evaluated for NMJ blocking and anticholinesterase activity in the current study.
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Experimental section
General
Melting points were determined on a Veego melting point apparatus and are uncorrected.
UV (wavelengths in nm) spectra were recorded on Lambda 15 and IR (wave numbers in cm -1 ) spectra on Perkin-Elmer spectrum RX 1, FT-IR spectrophotometer models using KBr pellets. 16a-Bromo-17-oxo-5-androsten-3b-ol (2) was synthesized according to reported procedure [22] .
Preparation of 16a
androsten-3b-ol (2, 1 g, 2.72 mmol) was dissolved in a mixture of cyclohexanone (10 mL) and dry toluene (100 mL). Traces of moisture were removed by azeotropic distillation of toluene. The distillation was continued at a slow rate while adding a solution of aluminium isopropoxide (1 g) in dry toluene (20 mL) dropwise. The reaction mixture was refluxed for 1 h and allowed to stand at room temperature overnight. The slurry was filtered and the residue was washed with dry toluene. (DDQ, 0.5 g) was heated under reflux in dry dioxane (50 mL) for 50 h. The progress of the reaction was monitored by TLC. The reaction mixture was cooled at room temperature and filtered. Chloroform (50 mL) was added to the filtrate and washed with 1% aqueous solution of potassium hydroxide (2 x 25 mL) and then with water to neutrality. The organic layer was dried and removed under vacuum to yield an oily residue, which revealed two spots on TLC and were separated by fractional crystallization. The oily residue was refluxed with diethyl ether, filtered and filtrate was concentrated to afford crystals of 16a-isomer 4a (30%). The residue left was crystallized from a mixture of petroleum ether and diethyl ether to obtain 16β-isomer 4b (70%). 
General procedure for the synthesis of compounds 5-7
A finely triturated mixture of requisite bromo steroid 2-4 (1g, 2.74 mmol) and powdered imidazole (1.5g, 10 mmol) was heated at 130-135 o C for 1 h. The reaction mixture was cooled to room temperature and cold water was added to it. The solid obtained was filtered, washed with water, dried and crystallized from a mixture of acetone and nhexane to afford 5-7, respectively 
2.1.3a. 16b-(Imidazol-1-yl)-17-oxo-5-androsten-3b-ol (5) (DPJ-RG-1240)
2.1.3b. 16b-(Imidazol-1-yl)-4-androstene-3,17-dione (6) (DPJ-RG-1241)
16b-(Imidazol-1-yl)-5-androstene-3b,17b-diol (8) (DPJ-RG-1317)
16b-(Imidazol-1-yl)-3b-pyrrolidino-5-androsten-17b-ol (11) (DPJ-RG-1319).
Pyrrolidine (1 mL) was added to a refluxing solution of 16b-(imidazol-1-yl)-4-androstene-3,17-dione (6, 1 g, 2.84 mmol) in methanol (20 mL). The reaction mixture was further refluxed for 1 h and chilled on ice. The crystalline material 10 obtained was filtered, washed with methanol and immediately used for further reaction.
To a stirred suspension of above obtained 16b-(imidazol-1-yl)-3-pyrrolidino-3,5-androstadiene-17-one (10) in methanol (100 mL) at room temperature, sodium borohydride (1 g) was added in small amounts over a period of 2 h at room temperature 
General procedure for the synthesis of compounds 9 and 12
A mixture of compound 8 or 11 (2.80 mmol), acetic anhydride (2 ml) and dry pyridine (2 ml) was heated in a steam bath for 2 h. The reaction contents were then poured into cold water and basified with liquid ammonia. The precipitate obtained was filtered, washed with water, dried and crystallized from acetone to afford 9 and 12, respectively. 
2.1.6a. 16b-(Imidazol-1-yl)-5-androstene-3b,17b-diol diacetate (9) (DPJ-RG-1318)
General procedure for the synthesis of compounds 13 and 14
Methyl iodide (2.0 ml) was added to a solution of compound 11 or 12 (0.15 g, mmol) in dichloromethane (20.0 ml). The reaction mixture was left at room temperature for 7 days and stirred intermittently. The solvent was removed under reduced pressure and the residue was treated with dry solvent ether to remove impurities. The solid obtained was dried and crystallized from dry diethylether in case of 13 and from a mixture of dry methanol-acetone for 14. 
2.1.7a. 16β-(1-Imidazolyl)-3β-pyrrolidino-5-androsten-17β-ol dimethiodide (13)
90%
2.2.Biological activity
2.2.1.Antineoplastic activity
The synthesized compounds were screened at National Cancer Institute, Bethesda, USA for in vitro antineoplastic activity.
60-Cell line assay
The compounds protein assay was used to estimate the cell viability or growth [23, 24] . Mean log dose response parameters such as GI50 (drug concentration resulting in a 50% reduction in the net protein increase), TGI (drug concentration for total growth inhibition) and LC50
(concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning) were calculated. Two standard drugs, meaning that their activities against the cell lines are well documented, were tested against each cell line: NSC 19893 (5-Fluorouracil) and NSC 123127 (Adriamycin).
Aromatase inhibitory activity 2.2.2a Preparation of aromatase
The enzyme was obtained from the microsomal fraction of freshly delivered human term placental tissue according to the procedure of Thompson and Siiteri [25] . The isolated microsomes were suspended in the minimum volume of phosphate buffer (0.05 M, pH 7.4, 20% glycerol). Additionally DTT (dithiothreitol, 10 mM) and EDTA (1 mM) were added to protect the enzyme from degradation. The enzyme preparation was stored at -70 °C as described. No loss of activity was observed within four months.
2.2.2b. Inhibition of aromatase in vitro
The assay was performed similar to the described methods [26] [27] [28] From this the molar concentration causing 50% inhibition was calculated.
2.2.2c. Irreversible inhibition of aromatase
The assay was performed similar to the test procedure described above. A preincubation of the aromatase containing microsomes was performed along with a regenerating system 
Neuromuscular blocking activity
Quaternary ammonium steroids 13 and 14 were screened for in vitro neuromuscular blocking activity using paralysis in chicks [29] , Rabbit head drop method U.S.P.1975 [30] and isolated frog rectus abdominis muscle preparation [31] .
2.2.3a.Paralysis in chicks
Paralysis in chicks was carried out as per the procedure described by Buttle and Zaimis [29] . Female layer chicks weighing between 20-25 gm were divided into 8 groups. Each group consisted of six chicks. Quaternary ammonium steroid 13 and 14 and d-tubocurarine were administrated at various doses intravenously in neck vein. The onset and duration of action of action was recorded. The end point was considered when the chick was unable to stand on its legs and showed a typical contracture with flaccid paralysis. The mean onset and duration of action against dose of drug with mean standard deviation was calculated.
2.2.3b.Rabbit head drop method
Rabbit head drop method was carried out as per USP-1975 [30] . New Zealand white rabbits weighing between 1.5-3 kg and of either sex were used. The rabbits were divided in two equal groups of at least four rabbits each. They were suitably restraint in prone position with the head free, taking precautions to prevent struggling. The standard drug was filled in a small bore burette which was joined with flexible polythene tube to a hypodermic needle (21 gauge) inserted in the marginal ear vein. The drug solution was administered at the rate of 0.1 ml every 15 seconds into each rabbit until head drop occurred. The end point was complete when rabbit was unable to raise and hold its head in response to a light tap on the back. The number of doses injected was recorded. The procedure was repeated in rabbits of both the groups. On the following day crossover was completed. Potency and confidence interval were calculated according to the method described in USP-1975
2.2.3c.Effect on isolated frog rectus abdominis muscle preparation
Frog rectus abdominis muscle preparation was carried out as described [31] . Standard procedure for setting up isolated tissue was used. Responses to various concentrations of acetylcholine were recorded. Frog ringer solution present in the reservoir was replaced by modified frog ringer solution containing test drug and responses to various concentrations to acetylcholine were recorded. Concentrations of acetylcholine were increased four times to study the nature of antagonism. Mean height of contractions was measured and a log dose response curve was plotted.
Anticholinesterase activity
The compound 13 was also tested for in vitro AChE inhibitory activity for its ability to inhibit the activity of electric eel acetylcholinesterase by modified Ellman method [32] .
Results and discussion
Chemistry
The synthetic routes to the preparation of various new steroidal derivatives have been outlined in schemes 1 and 2. Bromination of 1 was carried out using cupric bromide in dry methanol and dry benzene to afford 16-bromo-17-oxo-androsten-3-ol (2) [22] .
The configuration at position 16 has been assigned alpha in accordance with the earlier reports, which states that 16-and 16-protons in 16-bromosteroids resonates at  4.46 and 4.14 ppm, respectively [22, 33] . The proton NMR spectrum o f compound 2 exhibited a triplet at  4.55 ppm (16-H). Oppenauer oxidation of 2 using aluminium isopropoxidecyclohexanone-toluene system resulted into formation of a mixture of 16-bromo (16-H at 4.56, 40%) and 16β-bromo (16-H at 4.12, 60%) isomers of ,β-unsaturated ketosteroid compound 3. Such epimerization of 16-bromo-17-oxosteroids to the 16-isomer in alkaline medium has previously been reported [33] . Therefore synthetic route, where fusion with imidazole is the last step, was adopted for the synthesis of target compounds as shown in scheme 1. To improve the yield, microwave assisted synthesis [34] was also performed for synthesizing highly potent aromatase inhibitor 7 by fusion of bromo product 4 with imidazole. Although this method resulted in reduced reaction time from 30 min (conventional) to 15 min (microwave technique) but no significant change in yield was observed.
To study structure activity relationship in this particular series of compounds, further modifications of steroidal nucleus were carried out. Treatment of 16-imidazolyl steroid 5 with sodium borohydride in methanol at room temperature afforded 3,17-diol 8, which upon subsequent acetylation with acetic anhydride and dry pyridine in a steam bath yielded 3,17-diacetoxy derivative 9.
To create two bistertiary nitrogens with a central steroid nucleus, 16b-(imidazol-1-yl)-4-androstene-3,17-dione (6) was heated under reflux with freshly distilled pyrrolidine in methanol to furnish the unstable dienamine 10, which upon immediate reduction with sodium borohydride in methanol at room temperature afforded 3b-pyrrolidinyl derivative 11 as shown in scheme 2. Further acetylation of 11 using acetic anhydride and dry pyridine in a steam bath yielded 16-(imidazol-1-yl)-3-pyrrolidino-5-androsten-17-yl acetate (12) .
Bisquaternary ammonium steroids 13 and 14 were prepared by treating the bistertiary amines 11 and 12 with methyl iodide in dichloromethane at room temperature.
2-CH of imidazole resonated characteristically downfield at  9.91 ppm indicating the quaternization of imidazolyl nitrogen. The interonium distances of the quaternary compounds were calculated using drieding models, which indicated a value of 12.5 Å.
Biological activity
Newly synthesized 
Conclusions
The new steroidal analogues exhibited moderate cytotoxic effects in sixty cancer 
